Related references
Note: Only part of the references are listed.Regulation of T cell function by microRNA-720
Yu Wang et al.
SCIENTIFIC REPORTS (2015)
HBsAg seroclearance after nucleoside analogue therapy in patients with chronic hepatitis B: clinical outcomes and durability
Gi-Ae Kim et al.
GUT (2014)
Switching from entecavir to PegIFN alfa-2a in patients with HBeAg-positive chronic hepatitis B: A randomised open-label trial (OSST trial)
Qin Ning et al.
JOURNAL OF HEPATOLOGY (2014)
Predictors of response to pegylated interferon treatment in HBeAg-negative patients with chronic hepatitis B
Ertugrul Guclu et al.
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES (2014)
Serum HBV RNA and HBeAg are useful markers for the safe discontinuation of nucleotide analogue treatments in chronic hepatitis B patients
Masataka Tsuge et al.
JOURNAL OF GASTROENTEROLOGY (2013)
Effectiveness of Hepatitis B Treatment in Clinical Practice
Steven J. Scaglione et al.
GASTROENTEROLOGY (2012)
EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection
George Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2012)
Safety and efficacy of two-step peginterferon α-2a treatment in patients of chronic hepatitis B with acute exacerbation
C. -C. Chen et al.
JOURNAL OF VIRAL HEPATITIS (2012)
De novo combination of lamivudine and adefovir versus entecavir monotherapy for the treatment of na⟨ve HBeAg-negative chronic hepatitis B patients
Li-Chun Wang et al.
HEPATOLOGY INTERNATIONAL (2011)
Nucleoside/nucleotide analogues in the treatment of chronic hepatitis B
James Fung et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Hepatitis B Virus DNA Level Predicts Hepatic Decompensation in Patients With Acute Exacerbation of Chronic Hepatitis B
Wen-Juei Jeng et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2010)
Antiviral Resistance and Hepatitis B Therapy
Marc G. Ghany et al.
HEPATOLOGY (2009)
Chronic Hepatitis B: Update 2009
Anna S. F. Lok et al.
HEPATOLOGY (2009)
Sustained response to peginterferon alfa-2a (40 kD) with or without lamivudine in Asian patients with HBeAg-positive and HBeAg-negative chronic hepatitis B
Teerha Piratvisuth et al.
HEPATOLOGY INTERNATIONAL (2008)
Higher efficacy of sequential therapy with interferon-α and lamivudine combination compared to lamivudine monotherapy in HBeAg positive chronic hepatitis B patients
SK Sarin et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Peginterferon alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B
GKK Lau et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Long-term follow-up of peginterferon and lamivudine combination treatment in HBeAg-positive chronic hepatitis B
HLY Chan et al.
HEPATOLOGY (2005)
Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised
HLA Janssen et al.
LANCET (2005)
Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B
P Marcellin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Chronic hepatitis B virus infection in Asian countries
I Merican et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2000)